The new melanoma staging system

Tumori

Volumn 87, Issue 4, 2001, Pages

  Balch, C M ^a   Cascinelli, N ^a  

^a ASCO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; CONFERENCE PAPER; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MELANOMA; PROGNOSIS; TUMOR CLASSIFICATION;

HUMANS; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 0034810111     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Final version of the AJCC staging system for cutaneous melanoma
2. A new American Joint Committee on Cancer staging system for cutaneous melanoma
3. Prognostic factors analysis of 17,600 melanoma patients. Validation of the new AJCC melanoma staging system
4. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic
5. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma
6. Sentinel lymph node biopsy in cutaneous melanoma: The WHO Melanoma Program experience
7. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: A multicenter trial
8. Current status of intraoperative lymphatic mapping and sentinel lymphadenectomy for melanoma: Is it standard of care?
9. Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid
10. Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients
11. The prognostic significance of microscopic tumor burden in 925 melanoma patients undergoing sentinel lymph node biopsy
12. High- and low-dose interferon alfa-2b in high-risk melanoma: First analysis of intergroup trial E1690/S9111/C9190
13. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II)
14. A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia
15. Cutaneous melanoma: Prognosis and treatment results worldwide
16. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system
17. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases
18. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness